InvestorsHub Logo
Followers 15
Posts 1189
Boards Moderated 1
Alias Born 12/31/2008

Re: None

Friday, 09/09/2011 7:26:19 AM

Friday, September 09, 2011 7:26:19 AM

Post# of 7054
A short mention in the Philly Biz Journal. Includes a big photo of Mr. Pernock's head.

-------------------------------

http://www.bizjournals.com/philadelphia/print-edition/2011/09/09/fibrocell-irons-out-strategy-for.html

EXTON — Fibrocell Science Inc. is launching its regenerative cell therapy wrinkle treatment this month in Philadelphia and a half dozen other key markets around the country.
In addition to here, the Chester County biotechnology company plans to market laViv in Southern California, Atlanta, New York, Dallas, South Florida, and Washington, D.C.
“Our goal is to build long-term relationships with our physicians and our patients,” said David Pernock, Fibrocell’s CEO. “We believe it’s better to do things the right way, rather than doing things fast.”

Pernock declined to disclosed more details about the rollout for LaViv citing competitive reasons. Fibrocell ...

http://assets.bizjournals.com/philadelphia/print-edition/9-9%20David%20Pernock.jpg?v=1


These thoughts are just mine, not right, not wrong, just thoughts. Invest in what you believe in, not what I believe in. Do your research, and invest in the facts.